Skip to main content
. Author manuscript; available in PMC: 2022 Sep 15.
Published in final edited form as: J Immunol. 2021 Aug 18;207(6):1522–1529. doi: 10.4049/jimmunol.2100379

Table 3:

The risk of atopic dermatitis for KIR gene and reported HLA Class I epitope (as a composite) with respect to atopic dermatitis by ancestry presented with odds ratio and 95% confidence interval.

Composite Full Cohort European Ancestry African Ancestry
KIR HLA ligand OR (95% CI) OR (95% CI) OR (95% CI)
2DS2 C1 0.88 (0.66,1.18) 0.79 (0.54,1.15) 1.42 (0.84,2.40)
2DL2 C1 0.90 (0.67,1.20) 0.76 (0.52,1.10) 1.53 (0.91,2.57)
2DL3 C1 0.97 (0.71,1.32) 1.17 (0.77,1.78) 0.91 (0.55,1.50)
2DL1 C2 0.95 (0.71,1.27) 0.99 (0.68,1.44) 1.27 (0.77,2.09)
3DL1 Bw4 0.96 (0.72,1.28) 0.86 (0.59,1.25) 1.31 (0.80,2.17)
3DS1 Bw4 1.14 (0.79,1.63) 1.25 (0.81,1.93) 1.39 (0.63,3.05)
2DS1 C2 1.48 (1.04,2.12)
p=0.003
1.48 (0.96,2.28) 2.68 (1.23,5.82)
p=0.01
2DS5 C2 1.74 (1.21,2.51)
p=0.003
1.68 (1.06,2.68)
p=0.02
2.23 (1.17,4.25)
p=0.01